regulusrx.com is a domain that was created on 2007-01-03,making it 17 years ago. It has several subdomains, such as ir.regulusrx.com , among others.
Discover regulusrx.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 34.462 KB |
Page Load Time: 0.23144 Seconds |
Website IP Address: 104.154.80.234 |
Aratana Therapeutics Investor Overview aratana.investorroom.com |
Join the Spark Team – Spark Therapeutics jobs.sparktx.com |
Avenue Therapeutics, Inc. (ATXI) ir.avenuetx.com |
Viridian Therapeutics, Inc. - Investors & Media investors.viridiantherapeutics.com |
Clinical Pharmacology and Therapeutics Jobs - American Society for Clinical Pharmacology and Therape careers.ascpt.org |
Homepage | Drug and Therapeutics Bulletin dtb.bmj.com |
Amicus Therapeutics to Announce Full-Year 2019 Financial ir.amicusrx.com |
Nutritional Supplements | Integrative Therapeutics go.integrativepro.com |
Investor Relations :: Checkpoint Therapeutics, Inc. (CKPT) ir.checkpointtx.com |
Investor Relations | TG Therapeutics, Inc. ir.tgtherapeutics.com |
Investors | Horizon Therapeutics plc ir.horizon-pharma.com |
Home | Journal of Pharmacology and Experimental Therapeutics jpet.aspetjournals.org |
Acorda Therapeutics Grant Application Portal grants.acorda.com |
Overview - Regulus Therapeutics ir.regulusrx.com |
Regulus Therapeutics https://www.regulusrx.com/ |
About microRNAs. https://www.regulusrx.com/technology/ |
About https://www.regulusrx.com/about/ |
Publications https://www.regulusrx.com/publications/ |
Regulus Therapeutics: Overview https://ir.regulusrx.com/ |
Patients https://www.regulusrx.com/patients/ |
Careers https://www.regulusrx.com/careers/ |
Terms and Conditions of Use – Regulus Therapeutics https://www.regulusrx.com/terms-conditions/ |
Privacy Policy https://www.regulusrx.com/privacy-policy/ |
Regulus Therapeutics Announces Positive Topline Safety and ... https://ir.regulusrx.com/2022-09-12-Regulus-Therapeutics-Announces-Positive-Topline-Safety-and-Pharmacokinetic-PK-Data-from-the-Phase-1-Single-Ascendi |
Regulus Therapeutics Announces First Patient Dosed in Second Cohort of ... https://ir.regulusrx.com/2023-06-27-Regulus-Therapeutics-Announces-First-Patient-Dosed-in-Second-Cohort-of-Phase-1b-Multiple-Ascending-Dose-MAD-Clinic |
Regulus Therapeutics Announces Strategic Prioritization of RGLS8429 ... https://ir.regulusrx.com/2021-10-12-Regulus-Therapeutics-Announces-Strategic-Prioritization-of-RGLS8429,-its-Next-Generation-Candidate-for-the-Treatme |
Regulus Therapeutics Announces First Subject Dosed in Phase 1 Single ... https://ir.regulusrx.com/2022-06-13-Regulus-Therapeutics-Announces-First-Subject-Dosed-in-Phase-1-Single-Ascending-Dose-SAD-Clinical-Trial-of-RGLS8429 |
Investors - Regulus Therapeutics - Fundamentals https://ir.regulusrx.com/fundamentals |
A regulusrx.com. 600 IN A 104.154.80.234 |
MX regulusrx.com. 600 IN MX 0 regulusrx-com.mail.protection.outlook.com. |
NS regulusrx.com. 3600 IN NS ns51.domaincontrol.com. |
TXT regulusrx.com. 1800 IN TXT v=spf1 ip4:70.167.177.224/28 include:spf.protection.outlook.com include:mxlogic.net -all |
SOA regulusrx.com. 3600 IN SOA ns51.domaincontrol.com. dns.jomax.net. 2024022300 28800 7200 604800 3600 |
Server: nginx |
Date: Tue, 14 May 2024 18:58:28 GMT |
Content-Type: text/html; charset=UTF-8 |
Content-Length: 31981 |
Connection: keep-alive |
Keep-Alive: timeout=20 |
Vary: Accept-Encoding, Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie |
Link: https://www.regulusrx.com/wp-json/; rel="https://api.w.org/", https://www.regulusrx.com/wp-json/wp/v2/pages/9; rel="alternate"; type="application/json", https://www.regulusrx.com/; rel=shortlink |
X-Powered-By: WP Engine |
X-Cacheable: SHORT |
Cache-Control: max-age=600, must-revalidate |
Accept-Ranges: bytes |
X-Cache: HIT: 3 |
X-Cache-Group: normal |
charset="utf-8"/ |
content="width=device-width, initial-scale=1" name="viewport"/ |
content="max-image-preview:large" name="robots" |
Ip Country: United States |
City Name: Council Bluffs |
Latitude: 41.2591 |
Longitude: -95.8517 |
Technology Overview Mechanism of Action Pipeline ADPKD Patients Investors Overview Press Releases Events and Presentations Financials & Filings SEC Filings Quarterly Results Corporate Governance Governance Documents Board of Directors Committee Composition Analyst Coverage Stock Information Historical Stock Price Investment Calculator Insider Transactions Fundamentals Form 8937 Investor FAQs Contact Us Careers Delivering life-changing therapeutics to patients with orphan kidney diseasesWe are laser-focused on our mission: to improve the lives of patients and their families. Clinical Trials Our pipeline programs target kidney diseases of high unmet need, including ADPKD. Programs We are targeting the underlying biology of these diseases with a novel and potentially powerful approach: MicroRNA-based therapeutics. Technology News . May 9, 2024 Reports First Quarter 2024 Financial Results and Recent Updates May 6, 2024 Advances to Cohort 4 of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) April 30, 2024 to Participate in the Canaccord Genuity Genetic Medicine for Generalists Webcast Series MORE NEWS Copyright 2024 – All rights reserved Terms and...
Domain Name: REGULUSRX.COM Registry Domain ID: 737920093_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2024-01-04T18:18:37Z Creation Date: 2007-01-03T21:42:22Z Registry Expiry Date: 2029-01-03T21:42:22Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS51.DOMAINCONTROL.COM Name Server: NS52.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:57:17Z <<<